Skip to main content
. 2019 Jul 9;10(5):1595–1622. doi: 10.1007/s13300-019-0657-8

Fig. 5.

Fig. 5

SGLT2i treatment efficacy in people both with and without established CVD or HF [97]. a Meta-analysis of MACE outcomes stratified by presence of established CVD. b Meta-analysis of HHF and CV death stratified by presence of established CVD. c Meta-analysis of HHF and CV death stratified by history of HF.

Adapted with permission from Zelniker et al. [97]